These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34925367)

  • 1. Inducible T-Cell Costimulator Mediates Lymphocyte/Macrophage Interactions During Liver Repair.
    Ramavath NN; Gadipudi LL; Provera A; Gigliotti LC; Boggio E; Bozzola C; Albano E; Dianzani U; Sutti S
    Front Immunol; 2021; 12():786680. PubMed ID: 34925367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis.
    Provera A; Ramavath NN; Gadipudi LL; Gigliotti CL; Boggio E; Vecchio C; Stoppa I; Rolla R; Boldorini R; Pirisi M; Smirne C; Albano E; Dianzani U; Sutti S
    Front Immunol; 2023; 14():1290391. PubMed ID: 38077334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible costimulator (ICOS) and ICOS ligand signaling has pivotal roles in skin wound healing via cytokine production.
    Maeda S; Fujimoto M; Matsushita T; Hamaguchi Y; Takehara K; Hasegawa M
    Am J Pathol; 2011 Nov; 179(5):2360-9. PubMed ID: 21925472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ICOSL Stimulation by ICOS-Fc Accelerates Cutaneous Wound Healing In Vivo.
    Stoppa I; Gigliotti CL; Clemente N; Pantham D; Dianzani C; Monge C; Puricelli C; Rolla R; Sutti S; Renò F; Boldorini R; Boggio E; Dianzani U
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis.
    Alves GF; Stoppa I; Aimaretti E; Monge C; Mastrocola R; Porchietto E; Einaudi G; Collotta D; Bertocchi I; Boggio E; Gigliotti CL; Clemente N; Aragno M; Fernandes D; Cifani C; Thiemermann C; Dianzani C; Dianzani U; Collino M
    Front Immunol; 2022; 13():992614. PubMed ID: 36119089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep Flow Cytometry Unveils Distinct Immune Cell Subsets in Inducible T Cell Co-Stimulator Ligand (ICOSL)- and ICOS-Knockout Mice during Experimental Autoimmune Encephalomyelitis.
    Raineri D; Abreu H; Vilardo B; Kustrimovic N; Venegoni C; Cappellano G; Chiocchetti A
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ICOS ligand and IL-10 synergize to promote host-microbiota mutualism.
    Landuyt AE; Klocke BJ; Duck LW; Kemp KM; Muir RQ; Jennings MS; Blum SI; Tse HM; Lee G; Morrow CD; Elson CO; Maynard CL
    Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33753483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICOS/ICOSL upregulation mediates inflammatory response and endothelial dysfunction in type 2 diabetes mellitus.
    Zhang HY; Ruan LB; Li Y; Yang TR; Liu WJ; Jiang YX; Li TR; Quan J; Xuan W
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8898-8908. PubMed ID: 30575933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible costimulator ligand regulates bleomycin-induced lung and skin fibrosis in a mouse model independently of the inducible costimulator/inducible costimulator ligand pathway.
    Tanaka C; Fujimoto M; Hamaguchi Y; Sato S; Takehara K; Hasegawa M
    Arthritis Rheum; 2010 Jun; 62(6):1723-32. PubMed ID: 20191584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engagement of the costimulatory molecule ICOS in tissues promotes establishment of CD8
    Peng C; Huggins MA; Wanhainen KM; Knutson TP; Lu H; Georgiev H; Mittelsteadt KL; Jarjour NN; Wang H; Hogquist KA; Campbell DJ; Borges da Silva H; Jameson SC
    Immunity; 2022 Jan; 55(1):98-114.e5. PubMed ID: 34932944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis of peripheral T cells in rodent cardiac allograft recipients induced by donor-specific transfusion with impaired inducible costimulator/B7 homologous protein allorecognition.
    Du JF; Shen XF; Ji XQ; Chen G; Bai X; Zuo FY; Yu B
    Transplant Proc; 2013 Mar; 45(2):564-8. PubMed ID: 23498793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein A4 regulates the immune response in carbon tetrachloride-induced chronic liver injury in mice.
    Wang Y; Yang Z; Wei Y; Li X; Li S
    Int Immunopharmacol; 2021 Jan; 90():107222. PubMed ID: 33276196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible T-cell co-stimulator (ICOS) and ICOS ligand are novel players in the multiple-myeloma microenvironment.
    Boggio E; Gigliotti CL; Moia R; Scotta A; Crespi I; Boggione P; De Paoli L; Deambrogi C; Garzaro M; Vidali M; Chiocchetti A; Stoppa I; Rolla R; Dianzani C; Monge C; Clemente N; Gaidano G; Dianzani U
    Br J Haematol; 2022 Mar; 196(6):1369-1380. PubMed ID: 34954822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus restricts ICOSL expression on antigen-presenting cells disabling T cell co-stimulation and contributing to immune evasion.
    Angulo G; Zeleznjak J; Martínez-Vicente P; Puñet-Ortiz J; Hengel H; Messerle M; Oxenius A; Jonjic S; Krmpotić A; Engel P; Angulo A
    Elife; 2021 Jan; 10():. PubMed ID: 33459589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ICOS regulates the generation and function of human CD4+ Treg in a CTLA-4 dependent manner.
    Zheng J; Chan PL; Liu Y; Qin G; Xiang Z; Lam KT; Lewis DB; Lau YL; Tu W
    PLoS One; 2013; 8(12):e82203. PubMed ID: 24312642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmented ICOS expression in patients with early diffuse cutaneous systemic sclerosis.
    Hasegawa M; Fujimoto M; Matsushita T; Hamaguchi Y; Takehara K
    Rheumatology (Oxford); 2013 Feb; 52(2):242-51. PubMed ID: 23024058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unbalanced expression of membrane-bound and soluble inducible costimulator and programmed cell death 1 in patients with myasthenia gravis.
    Yan X; Gu Y; Wang C; Sun S; Wang X; Tian J; Wang M; Ji X; Duan X; Gao H; Fang Q; Dong W; Zhang X; Xue Q
    Clin Immunol; 2019 Oct; 207():68-78. PubMed ID: 31374257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).
    Taylor PA; Panoskaltsis-Mortari A; Freeman GJ; Sharpe AH; Noelle RJ; Rudensky AY; Mak TW; Serody JS; Blazar BR
    Blood; 2005 Apr; 105(8):3372-80. PubMed ID: 15618467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective Role of ICOS and ICOS Ligand in Corneal Transplantation and in Maintenance of Immune Privilege.
    Kunishige T; Taniguchi H; Terada M; Akiba H; Yagita H; Abe R; Hori J
    Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6815-6823. PubMed ID: 28002569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of ICOSL/ICOS pathway-regulated long non-coding RNAs on liver fibrosis in mice infected with Schistosoma japonicum.
    Huang P; Xu J; Jiang S; Zhang Y; Wang X; Xiong C; Xia C
    Parasit Vectors; 2024 Jul; 17(1):317. PubMed ID: 39044218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.